Acute Myeloid Leukemia Clinical Trial

Clinical Trial Finder Acute Myeloid Leukemia Trials

Expanded Access for CC-486

See Locations Near You

Summary

This is an expanded access program (EAP) for eligible participants designed to provide access to CC-486.

View Eligibility Criteria

Eligibility Criteria

Inclusion Criteria:

-Adult patients with documented acute myelogenous leukemia (AML) in their first complete remission (CR) or complete remission with incomplete blood count recovery (CRi) following induction therapy with or without consolidation treatment, who seek treatment with CC-486 as monotherapy to maintain their CR or CRi.

Exclusion Criteria:

Patients with AML in CR/CRi who plan to proceed to or are waiting for a bone marrow transplant
Patients who have received a bone marrow transplant for the treatment of AML
Treatment of AML patients with relapse or refractory disease
Pregnant or breast-feeding females
Patient meets enrollment criteria and can participate in a disease-specific clinical trial

Study is for people with:

Acute Myeloid Leukemia

Study ID:

NCT03723135

Recruitment Status:

Approved for marketing

Sponsor:

Celgene

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There is 1 Location for this study

See Locations Near You

Celgene
Summit New Jersey, 07901, United States

How clear is this clinincal trial information?

Study is for people with:

Acute Myeloid Leukemia

Study ID:

NCT03723135

Recruitment Status:

Approved for marketing

Sponsor:


Celgene

How clear is this clinincal trial information?

Clinical Trial Resources

Why I’d Choose a Clinical Trial For Myself
SurvivorNet’s Guide To Clinical Trials: What Are They And Are They Right for You?
Clinical Trials Can be Life-Saving for Some
×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.

Please confirm you are a US based health care provider:

Yes, I am a health care Provider No, I am not a health care provider